Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability.

TL;DR: Initial studies in drug developments involve the synthesis and extraction of new compounds, their biological screening and pharmacological testing, followed by small animal model testing of toxicology and safety profiles, which guide researchers to formulate effective pharmaceutical dosage, in vivo stability, elimination and eventually the therapeutic index of lead compounds.

TL;DR: In this paper, the authors evaluated the association between MDR1 gene polymorphisms and hepatocellular carcinoma (HCC) risk using the created restriction site-polymerase chain reaction (CRS-PCR).

TL;DR: A meta-analysis suggests that the MDR1 C3435T polymorphism associate with risk of leukaemia, and the effect of the variant on the expression levels and the possible functional role of the variants in leukaemi should be addressed in further studies.

TL;DR: Wang et al. as mentioned in this paper performed a meta-analysis to further evaluate the impacts of ABCB1 polymorphisms on CBZ metabolism and resistance, and found that the TC genotype (heterozygous model: TC vs. CC) of rs1045642 polymorphism was significantly connected with decreased CBZ concentration.

TL;DR: A significant correlation of a polymorphism in exon 26 (C3435T) of MDR-1 with expression levels and function is observed and this polymorphism is expected to affect the absorption and tissue concentrations of numerous other substrates of M DR-1.

TL;DR: Allelic variation in MDR1 is more common than previously recognized and involves multiple SNPs whose allelic frequencies vary between populations, and some of these SNPs are associated with altered P‐glycoprotein function.

TL;DR: Some synonymous mutations in the human DRD2 have functional effects and suggest a novel genetic mechanism, calling into question some assumptions made about synonymous variation in molecular population genetics and gene-mapping studies of diseases with complex inheritance, and indicate that synonymous variation can have effects of potential pathophysiological and pharmacogenetic importance.

TL;DR: SNPs in MDR1 in relation to population frequencies, drug levels, and phenotypes are outlined and issues relating to M DR1 haplotypes, environmental factors, and study design, as potential confounding factors of the observed MDR 1 polymorphism effect in vivo, are discussed.